Daniel Bernardini

Daniel Bernardini currently serves as the Chief Financial Officer at Health Genesis Corporation since July 2023. Prior experience includes key financial leadership roles at Merck from 1994 to 2023, where responsibilities ranged from managing accounting processes across regions as the Director, Global Process Owner for Account to Report, to overseeing US GAAP accounting activities and compliance as the CFO for Shared Services Americas. Additionally, in earlier positions within Merck, Daniel led finance teams for Latin America and contributed significantly to financial forecasting and cash management. Earlier career roles include financial planning and accounts payable analysis at Wyeth and Pepsi y Hit de Venezuela, respectively. Educational credentials include a Master's degree in Business Management from Universidad Metropolitana and a Bachelor's degree in Business Administration from Universidad Nueva Esparta.